Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases

Hepatology

Volumn 24, Issue 3, 1996, Pages 524-532

  Roskams, Tania ^a,c   Rosenbaum, Jean ^b   De Vos, Rita ^a   David, Guido ^a   Desmet, Valeer ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b INSERM   (France)

^c UZ St Raphael   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PERLECAN; PROTEOHEPARAN SULFATE; SYNDECAN;

ARTICLE; CHOLESTASIS; CHOLESTATIC HEPATITIS; CONTROLLED STUDY; EXTRAHEPATIC BILE DUCT OBSTRUCTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LIVER BIOPSY; NODULAR HYPERPLASIA; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

EID: 0029816535     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008781318     Document Type: Article

References (51)

1. Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem 1991; 60:443-475.
2. David G. Integral membrane heparan sulfate proteoglycans. Faseb Journal 1993; 7:1023-1030.
3. Roskams T, Moshage H, De Vos R, David G, Yap P, Desmet V. Integral membrane and matrix heparan sulfate proteoglycan expression in normal human liver. HEPATOLOGY 1995; 21:950-958.
4. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991; 64:841-884.
5. Lyon M, Deakin JA, Mizuno K, Nakamura T, Gallagher JT. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J Biol Chem 1994; 269:11216-11223.
6. Masumoto A, Yamamoto N. Stimulation of DNA synthesis in hepatocytes by hepatocyte growth factor bound to extracellular matrix. Biochem Biophys Res Commun 1993; 191:1218-1223.
7. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 1992; 8:365-393.
8. Clément B, Loréal O, Rescan P-Y, Levavasseur F, Diakonova M, Rissel M, L'Helgoualc'h A, et al. Cellular origin of the hepatic extracellular matrix. In: Gressner AM, Ramadori G, eds. Molecular and Cell Biology of Liver Fibrogenesis. Dordrecht: Kluwer Academic 1992:85-98.
9. Milani S, Herbst H, Schuppan D, Kim KY, Riecken EO, Stein H. Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. Gastroenterology 1990; 98:175-184.
10. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 1990; 85:1833-1843.
11. Takahara T, Kojima T, Miyabayashi C, Inoue K, Sasaki H, Muragaki Y, Ooshima A. Collagen production in fat-storing cells after carbon tetrachloride intoxication in the rat. Immunoelectron microscopic observation of type I, type III collagens, and prolyl hydroxylase. Lab Invest 1988; 59:509-521.
12. Lories V, Cassiman JJ, Van den Berghe H, David G. Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts. J Biol Chem 1992; 267:1116-1122.
13. Lories V, Cassiman JJ, Van den Berghe H, David G. Multiple distinct membrane heparan sulfate proteoglycans in human lung fibroblasts. J Biol Chem 1989; 264:7009-7016.
14. David G, van der Schueren B, Marynen P, Cassiman JJ, van den Berghe H. Molecular cloning of amphiglycan, a novel integral membrane heparan sulfate proteoglycan expressed by epithelial and fibroblastic cells. J Cell Biol 1992; 118:961-969.
15. David G, Lories V, Decock B, Marynen P, Cassiman JJ, Van den Berghe H. Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts. J Cell Biol 1990; 111: 3165-3176.
16. Heremans A, van der Schueren B, de Cock B, Paulsson M, Cassiman JJ, van den Berghe H, David G. Matrix-associated heparan sulfate proteoglycan: core protein-specific monoclonal antibodies decorate the pericellular matrix of connective tissue cells and the stromal side of basement membranes. J Cell Biol 1989; 109:3199-3211.
17. David G, Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 1992; 119:961-975.
18. De Vos R, De Wolf-Peeters C, van den Oord JJ, Desmet V. A recommended procedure for ultrastructural immunohistochemistry on small human tissue samples. J Histochem Cytochem 1985; 33:959-964.
19. Rosenbaum J, Mallat A, Preaux AM, Mavier P, Zafrani ES, Dhumeaux D. Effect of polypeptide growth factors on the growth of cultured human hepatic myofibroblast-like cells (transformed Ito cells). In: Wisse E, Knook DL, McCuskey RS, eds. Cells of the hepatic sinsoid. Vol III. Rijswijk: The Kupffer Cell Foundation; 1991:255-258.
20. Win KM, Charlotte F, Mallat A, Cherqui D, Martin N, Mavier P, Preaux AM, et al. Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. HEPATOLOGY 1993; 18:137-145.
21. Mertens G, Cassiman JJ, Van den Berghe H, Vermylen J, David G. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J Biol Chem 1992; 267:20435-20443.
22. Desmet VJ. Modulation of biliary epithelium. In: Reutter W, Popper H, Arias IM, Heinrich PC, Keppler D, et al, eds. Modulation of liver cell expression. Lancaster: M.T.P. Press Limited, Kluwer Academic 1987:195-214.
23. Abdel-Aziz G, Lebeau G, Rescan PY, Clement B, Rissel M, Deugnier Y, Campion JP, et al. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol 1990; 137:1333-1334.
24. Hines JE, Johnson SJ, Burt AD. In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. Am J Pathol 1993; 142:511-518.
25. Callea F, Mebis J, Desmet VJ. Myofibroblasts in focal nodular hyperplasia of the liver. Virchows Archiv Pathol Anat Histopathol 1982; 396:155-166.
26. Callea F, Desmet VJ. Transformation of fat storing cells (Ito cells) to myofibroblasts [Abstract]. J Hepatol 1985; 2 (suppl):S206.
27. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991; 139:1221-1229.
28. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989; 84:1786-1793.
29. Friedman SL, Arthur MJ. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest 1989; 84:1780-1785.
30. Meyer DH, Bachem MG, Gressner AM. Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha. Biochem Biophys Res Commun 1990; 171:1122-1129.
31. Charlotte F, Win KM, Preaux AM, Mavier P, Dhumeaux D, Zafrani ES, Rosenbaum J. Immunolocalization of heparin-binding growth factors (HBGF) types 1 and 2 in rat liver. Selective hyperexpression of HBGF-2 in carbon tetrachloride-induced fibrosis. J Pathol 1993; 169:471-476.
32. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E, Leder P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 1992; 12:240-247.
33. Nugent MA, Edelman ER. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. Biochemistry. 1992; 31:8876-8883.
34. Roghani M, Moscatelli D. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms. J Biol Chem 1992; 267:22156-22162.
35. Flaumenhaft R, Moscatelli D, Saksela O, Rifkin DB. Role of extracellular matrix in the action of basic fibroblast growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol 1989; 140:75-81.
36. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994; 79:1005-1013.
37. Raines EW, Ross R. Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences. J Cell Biol 1992; 116: 533-543.
38. Kelly JL, Sanchez A, Brown GS, Chesterman CN, Sleigh MJ. Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix. J Cell Biol 1993; 121:1153-1163.
39. Flaumenhaft R, Moscatelli D, Rifkin DB. Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J Cell Biol 1990; 111:1651-1659.
40. Clement B, Segui-Real B, Hassell JR, Martin GR, Yamada Y. Identification of a cell surface-binding protein for the core protein of the basement membrane proteoglycan. J Biol Chem 1989; 264:12467-12471.
41. Rescan PY, Loreal O, Hassell JR, Yamada Y, Guillouzo A, Clement B. Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture. Am J Pathol 1993; 142:199-208.
42. Koda JE, Bernfield M. Heparan sulfate proteoglycans from mouse mammary epithelial cells. Basal extracellular proteoglycan binds specifically to native type I collagen fibrils. J Biol Chem 1984; 259:11763-11770.
43. Saunders S, Bernfield M. Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for interstitial matrix. J Cell Biol 1988; 106:423-430.
44. Sun X, Mosher DF, Rapraeger A. Heparan sulfate-mediated binding of epithelial cell surface proteoglycan to thrombospondin. J Biol Chem 1989; 264:2885-2889.
45. Salmivirta M, Elenius K, Vainio S, Hofer U, Chiquet-Ehrismann R, Thesleff I, Jalkanen M. Syndecan from embryonic tooth mesenchyme binds tenascin. J Biol Chem 1991; 266:7733-7739.
46. Rapraeger A, Jalkanen M, Bernfield M. Integral membrane proteoglycans as matrix receptors: role in cytoskeleton and matrix assembly at the epithelial cell surface. In: Wight TN, Mecham RP, eds. Biology of extracellular matrix: a series. Biology of proteoglycans Vol 2. Orlando: Academic; 1987: 129-154.
47. Roskams T, van den Oord JJ, De Vos R, Desmet VJ. Neuroendocrine features of reactive bile ductules in cholestatic liver disease. Am J Pathol 1990; 137:1019-1025.
48. Roskams T, Campos RV, Drucker DJ, Desmet VJ. Reactive human bile ductules express parathyroid hormone-related peptide. Histopathol 1993; 23:11-19.
49. Cole GJ, Glaser L. A heparin-binding domain from N-CAM is involved in neural cell-substratum adhesion. J Cell Biol 1986; 102:403-412.
50. Cole GJ, Loewy A, Glaser L. Neuronal cell-cell adhesion depends on interactions of N-CAM with heparin-like molecules. Nature 1986; 320:445-447.
51. Desmet VJ. Modulation of the liver in cholestasis. J Gastroenterol Hepatol 1992; 7:313-323.